Proteome alterations in gamma-irradiated human T-lymphocyte leukemia cells

Radiation Research

Volumn 163, Issue 3, 2005, Pages 307-315

  Szkanderová, Sylva ^a   Vávrová, Jiřina ^a   Hernychová, Lenka ^a   Neubauerová, Věra ^a   Lenčo, Juraj ^a   Stulík, Jiří ^a  

^a DEPARTMENT OF TOXICOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EXPORTIN 5; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; PROTEIN SERINE THREONINE KINASE; PROTEOME; RAN BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; CELL FUNCTION; CELL LYSATE; CONTROLLED STUDY; DNA FINGERPRINTING; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMAGING SYSTEM; IMMUNOBLOTTING; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIATION RESPONSE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TWO DIMENSIONAL ELECTROPHORESIS;

CELL LINE, TUMOR; DNA DAMAGE; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GAMMA RAYS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOBLOTTING; LEUKEMIA, T-CELL; MASS SPECTROMETRY; PROTEOME; SIGNAL TRANSDUCTION; SILVER STAINING; T-LYMPHOCYTES; TIME FACTORS; UP-REGULATION;

EID: 14244273951     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3309     Document Type: Article

References (38)

1. W. F. Blakely, A. C. Miller, L. Luo, J. Lukas, Z. D. Hornby, C. J. Hamel, J. T. Nelson, N. E. Escalada and P. G. Prasanna, Nucleic acid molecular biomarkers for diagnostic biodosimetry applications: Use of the fluorogenic 5′-nuclease polymerase chain reaction assay. Mil. Med. 167, 16-19 (2002).
2. A. J. Fornace, S. A. Amundson, K. T. Do, P. Meltzer, J. Trent and M. Bittner, Stress-gene induction by low-dose gamma irradiation. Mil. Med. 167, 13-15 (2002).
3. M. A. Chaudhry, L. A. Chodosh, W. G. McKenna and R. J. Muschel, Gene expression profile of human cells irradiated in G, and G2 phases of cell cycle. Cancer Lett. 195, 221-233 (2003).
4. M. B. Grace, C. B. McLeland and W. F. Blakely, Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry. Int. J. Radiat. Biol. 78, 1011-1021 (2002).
5. W. Y. Park, C. I. Hwang, C. N. Im, M. J. Rang, J. H. Woo, J. H. Kim, Y. S. Kim, J. H. Kim, H. Kim and J. S. Seo, Identification of radiation-specific response from gene expression profile. Oncogene 21, 8521-8528 (2002).
6. H. Nakano and K. Shinohara, X-ray-induced cell death: Apoptosis and necrosis. Radiat. Res. 140, 1-9 (1994).
7. S. Szkanderová, J. Vávrová, M. Rezacová, D. Vokurková, S. Pavlová, J. Smardová and J. Stulik, Gamma irradiation results in phosphorylation of p53 at serine-392 in human T-lymphocyte leukaemia cell line MOLT-4. Fol. Biol. 49, 191-196 (2003).
8. J. Vávrová and S. Filip, Radiosensitivity of Hematopoetic System. Galén, Prague, 2002.
9. A. Görg, C. Obermaier, G. Boguth, A. Csordas, J-J. Diaz and J-J. Madjar, Very alkaline immobilized pH gradients for two-dimensional electrophoresis of ribosomal and nuclear proteins. Electrophoresis 18, 328-337 (1997).
10. R. E. Brown, K. L. Jarvis and K. J. Hyland, Protein measurement using bicinchoninic acid: Elimination of interfering substances. Anal. Biochem. 180, 136-139 (1989).
11. D. F. Hochstrasser and C. R. Merril, 'Catalysts' for polyacrylamide gel polymerization and detection of proteins by silver staining. Appl. Theor. Electrophor. 1, 35-40 (1988).
12. S. Lamer and P. R. Jungblut, Matrix-assisted laser desorption-ionization mass spectrometry peptide mass fingerprinting for proteome analysis: Identification efficiency after on-blot or in-gel digestion with and without desalting procedures. J. Chromatogr. B Biomed. Sci. Appl. 752, 311-322 (2001).
13. B. Thiede, F. Siejak, C. Dimmler and T. Rudel, Prediction of translocation and cleavage of heterogeneous ribonuclear proteins and Rho guanine nucleotide dissociation inhibitor 2 during apoptosis by subcellular proteome analysis. Proteomics 2, 996-1006 (2002).
14. S. Na, T. H. Chuang, A. Cunningham, T. G. Turi, J. H. Hanke, G. M. Bokoch and D. E. Danley, D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J. Biol. Chem. 271, 11209-11213 (1996).
15. K. B. Kwon, E. K. Park, D. G. Ryu and B. H. Park, D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells. Exp. Mol. Med. 34, 32-37 (2002).
16. F. Essmann, T. Wieder, A. Otto, E-C. Müller, B. Dörken and P. T. Daniel, GDP dissociation inhibitor D4-GDI (Rho-GDI2), but not the homologous Rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis. Biochem. J. 346, 777-783 (2000).
17. S. Szkanderová, L. Hernychová, I. Kasalová, J. Vavrová, J. Stulik, M. Abend and D. van Beuningen, Proteomic analysis of radiation-induced alterations in L929 cells. Fol. Biol. 49, 15-25 (2003).
18. G. Guarguaglini, L. Renzi, F. D'Ottavio, B. Di Fiore, M. Casenghi, E. Cundari and P. Lavia, Regulated Ran-binding protein 1 activity is required for organization and function of the mitotic spindle in mammalian cells in vivo. Cell Growth Differ. 11, 455-465 (2000).
19. L. Lim, E. Manser, T. Leung and C. Hall, Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways. Eur. J. Biochem. 242, 171-185.
20. U. G. Knaus and G. M. Bokoch, The p21Rac/Cdc42-activated kinases (PAKs). Int. J. Biochem. Cell Biol. 30, 857-862 (1998).
21. J. Roig and J. A. Traugh, p21-activated protein kinase γ-PAK is activated by ionizing radiation and other DNA-damaging agents. J. Biol. Chem. 274, 31119-31122 (1999).
22. B. N. Walter, Z. Huang, R. Jakobi, P. T. Tuazon, E. S. Alnemri, G. Litwack and J. A. Traugh, Cleavage and activation of p21-activated protein kinase γ-PAK by CPP32 (caspase 3). J. Biol. Chem. 273, 28733-28739 (1998).
23. R. Jakobi, E. Moertl and M. A. Koeppel, p21-activated protein kinase γ-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J. Biol. Chem. 276, 16624-16634 (2001).
24. T. Rudel, F. T. Zenke, T. H. Chuang and G. M. Bokoch, p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells. J. Immunol. 160, 7-11 (1998).
25. M. J. Lees, D. J. Peet and M. L. Whitelaw, Defining the role for XAP2 in stabilization of the dioxin receptor. J. Biol. Chem. 278, 35878-35888 (2003).
26. G. Thompson, D. Owen, P. A. Chalk and P. N. Lowe, Delineation of the Cdc42/Rac-binding domain of p21-activated kinase. Biochemistry 37, 7885-7891 (1998).
27. F. Pajonk and W. H. McBride, Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses. Radiother. Oncol. 59, 203-212 (2001).
28. T. Okamura, S. Taniguchi, T. Ohkura, A. Yoshida, H. Shimizu, M. Sakai, H. Maeta, H. Funuki, Y. Ueta, I. Hisatome and C. Shigemasa, Abnormally high expression of proteasome activator-gamma in thyroid neoplasm. J. Clin. Endocrinol. Metab. 88, 1374-1383 (2003).
29. V. A. Brophy, J. M. Tavare and A. J. Rivett, Treatment of COS-7 cells with proteasome inhibitors or gamma-interferon reduces the increase in caspase 3 activity associated with staurosporine-induced apoptosis. Arch. Biochem. Biophys. 397, 199-205 (2002).
30. U. A. Bommer and B. J. Thiele, The translationally controlled tumour protein (TCTP). Int. J. Biochem. Cell. Biol. 36, 379-385 (2004).
31. C. Baudet, E. Perret, B. Delpech, M. Kaghad, P. Brachet, D. Wion and D. Caput, Differentially expressed genes in C6.9 glioma cells during vitamin D-induced cell death program. Cell Death Differ. 5, 116-125 (1998).
32. E. D. Decker, Y. Zhang, R. R. Cocklin, F. A, Witzmann and M. Wang, Proteomic analysis of differential protein expression induced by ultraviolet light radiation in HeLa cells. Proteomics 3, 2019-2027 (2003).
33. U. C. Oppermann, S. Salim, L. O. Tjernberg, L. Terenius and H. Jornvall, Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): Regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease. FEBS Lett. 451, 238-242 (1999).
34. E. Brockstedt, A. Otto, A. Rickers, K. Bommert and B. Wittmann-Liebold, Preparative high-resolution two-dimensional electrophoresis enables the identification of RNA polymerase B transcription factor 3 as an apoptosis-associated protein in the human BL60-2 Burkitt lymphoma cell line. J. Protein Chem. 18, 225-231 (1999).
35. S. D. Davidson, J. P. Cherry, M. S. Choudhury, H. Tazaki, C. Mallouh and S. Konno, Glyoxalase I activity in human prostate cancer: A potential marker and importance in chemotherapy. J. Urol. 161, 690-691 (1999).
36. S. Ranganathan, E. S. Walsh and K. D. Tew, Glyoxalase I in detoxification: Studies using a glyoxalase I transfectant cell line. Biochem. J. 309, 127-131 (1995).
37. R. S. Luthra and R. K. Kale, Inhibition of radiation-induced changes of glyoxalase I activity in mouse spleen and liver by phenothiazines. Int. J. Radiat. Biol. 67, 403-410 (1995).
38. V. Badock, U. Steinhusen, K. Bommert and A. Otto, Prefractionation of protein samples for proteome analysis using reversed-phase high-performance liquid chromatography. Proteomics 22, 2856-2864 (2001).